MedPath

The efficacy and safety of etrifel saqir in obese patients with placebo

Phase 3
Conditions
Obesity.
Obesity due to excess calories
Registration Number
IRCT201104206237N1
Lead Sponsor
Shahed University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion Criteria: Having BMI more than 30; age between 16 to 60 years old;(Between50 to 60 with normal ECG) inform consent signed by the patient; those who can over the next three months five times refer for take drugs and laboratory examination and Waist circumference > 102 cm (men) or > 88 cm (women)

Exclusion Criteria

Heavy Smoking(More than twenty cigarettes per daily); pregnancy; patients with coronary heart vascular disease; diabetes mellitus; patients with proven malignancy, asthma, chronic cough, chronic lung inflammatory and bowel disease, fever of unknown origin; patients with a history of chronic kidney and liver disease(Exception fatty liver and not including obesity, allergies, skin problems, or occasional GERD or IBS symptoms); obesity due to endocrine (hypothyroidism, uncontrolled disease) disease; genetic obesity syndrome; patients treated recently with sliming drugs; patients in the last three months, have been taken thin regimes; having psychological problems(psychiatric disorder (including recent diagnosis depression, bipolar disorder, and anxiety determined by self-report during screening .( diagnosis in last three month); alcohol consumption; persons with weight loss after surgery and receiving corticosteroid or Immunosuppressive medications

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body Mass Index. Timepoint: Monthly. Method of measurement: Calculation of height and Weight.;Waist circumference. Timepoint: Monthly. Method of measurement: Metric.;Weight. Timepoint: Monthly. Method of measurement: Scale.;Volume hip circumference. Timepoint: Before intervention, 4weeks after intervention,8 weeks after intervention, 12 weeks after intervention. Method of measurement: Metric.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath